EUVIMED · CrossrefZeitschrift
Metabolic Brain Disease
ISSN 1573-7365 · Springer Science and Business Media LLC
Neueste Artikel
Piracetam modulates secondary injury responses and neuroplasticity-related alterations after mild traumatic brain injury
Astrocyte-related pathological mechanisms
Gold nanoparticles as a therapeutic strategy for Parkinson’s disease: a systematic review and exploratory quantitative synthesis
Dietary and endogenous fructose metabolism in Alzheimer’s disease: a critical review of mechanistic, preclinical, and epidemiological evidence
mGluR1-ERK1/2 signaling pathway induces neuronal apoptosis and necroptosis then contributes to long-term neurologic deficits after experimental subarachnoid hemorrhage
Carbonyl stress as the missing molecular link between diabetes and neurodegeneration: a unified mechanistic framework for type 3 diabetes
The protection of chronic cerebral ischemia by Hua-Feng-Dan involves the modulation of hippocampal transcriptome and gut dysbiosis
The hepatic secretome-microglia axis in huntington’s disease: Linking peripheral metabolic dysfunction to neuroinflammation and novel therapeutic opportunities
MitoQ alleviates thioacetamide-induced hepatic encephalopathy by restoring hippocampal mitochondrial homeostasis through PINK1/Parkin-mediated mitophagy
From multi-omics screening to functional validation: The SOD1-SIRT5 Axis as a potential mediator of ammonia-related neuronal injury and NAD⁺-based neuroprotection in epilepsy
Impaired brain reserve is associated with increased risk of overt hepatic encephalopathy occurrence in patients with cirrhosis
Blood-based multiplex nanobiosensing of Alzheimer’s disease biomarkers: from nanoengineered ınterfaces to clinical translation
CRISPR-Enabled functional genomics in hPSCs-derived neural models for autism spectrum disorder
Differential metabolic and cellular brain regional susceptibility in adult rats with chronic liver disease
Peripheral metabolic dysfunction is associated with cognitive frailty in a mouse model of type 2 diabetes
Exosome-derived biomarkers as non-invasive tools in stroke, Parkinson’s disease, and Alzheimer’s disease
The potential of vitamins in Huntington’s disease: bridging mechanistic evidence with translational limitations and future strategies
Berberine and lactulose combination therapy attenuates neuroinflammation and hepatic injury in thioacetamide-induced hepatic encephalopathy in rats
Hesperidin attenuates aluminum chloride-induced cognitive impairment by modulating ERK/MAPK Signaling, tau protein immunoexpression, neuroinflammation, and microglial activation in mice
Chiglitazar alleviates cognitive dysfunction in diabetic mice by restoring mitochondrial function via the PPARs/Nrf2 signaling pathway
Multi-omics analysis of untargeted metabolomics and gut microbiota study on the mechanism of Astragalus-Safflower to coordinate the regulation of energy metabolism pathways and gut microbiota remodeling to improve ischemic stroke
Majoon-e-Boolis as a neurotherapeutic agent: cognitive and neuronal restoration in alzheimer’s disease model
Integrative transcriptomic and genetic analysis implicates fatty acid metabolic reprogramming in perivascular macrophages in Alzheimer’s disease
Role of the TLR4–NF-κB–FDX1 cuproptosis axis in mediating cognitive impairment associated with type 1 diabetes in children: an exploratory mechanistic study
Oleuropein regulates neuronal survival and Histone acetylation in Parkinson’s disease: cellular and epigenetic insights
Polysaccharide-driven gut microbial metabolism in neurodegenerative brain diseases: from SCFAs and tryptophan catabolites to neuroinflammatory regulation
T3 and curcumin regulates collagen-IV and collagen-VI expression: role in suppression of amyloid-β via TGFβ1-Sp1 signaling in hypothyroid mice brain
Blockade of the SP/NK1 receptor axis: multimodal neuroprotection via inflammatory suppression, hypoxic modulation, and lympho-vascular remodeling in global cerebral ischemia
From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson’s disease
Pentoxifylline targets TLR4/MyD88/NF-κB signaling to ameliorate neuroinflammation and metabolic dysfunction in a rat model of chronic hypoperfusion-induced vascular cognitive impairment
Jahrgänge
2026 · 2472025 · 2672024 · 1622023 · 2592022 · 2362021 · 2172020 · 1332019 · 1642018 · 2072017 · 2232016 · 1622015 · 1682014 · 1152013 · 982012 · 702011 · 392010 · 552009 · 602008 · 412007 · 352006 · 312005 · 422004 · 402003 · 292002 · 522001 · 262000 · 471999 · 311998 · 351997 · 431996 · 341995 · 341994 · 321993 · 181992 · 191991 · 241990 · 211989 · 311988 · 291987 · 24
EUVIMED